CATO vs TSLA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CATO exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating a near-total failure of fundamental health metrics. While the stock appears superficially cheap with a Price/Book of 0.35 and Price/Sales of 0.09, these are classic 'value trap' indicators given the negative operating margins and declining revenue growth. The combination of a 0/100 technical trend and a -72.8% five-year price collapse suggests a company in structural decline. Without a significant operational turnaround, the current valuation does not provide a sufficient margin of safety.
Tesla's deterministic health is marginally stable with a Piotroski F-Score of 4/9, but the valuation is fundamentally decoupled from financial performance. The stock trades at a massive premium to its Graham Number ($23.07) and Intrinsic Value ($7.56), while exhibiting negative revenue growth (-3.10%) and a severe collapse in earnings growth (-60.60%). With zero earnings beats in the last four quarters and bearish insider activity, the current price is supported by sentiment rather than data.
Compare Another Pair
Related Comparisons
CATO vs TSLA: Head-to-Head Comparison
This page compares The Cato Corporation (CATO) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.